Zero tolerance for complacency by government of West African countries in the face of the COVID-19.
Identifieur interne : 000232 ( Main/Exploration ); précédent : 000231; suivant : 000233Zero tolerance for complacency by government of West African countries in the face of the COVID-19.
Auteurs : O. Erhabor [Nigeria] ; T. Erhabor [Nigeria] ; T C Adias [Nigeria] ; G C Okara [Nigeria] ; M. Retsky [États-Unis]Source :
- Human antibodies [ 1875-869X ] ; 2020.
Abstract
A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.
DOI: 10.3233/HAB-200413
PubMed: 32417768
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Zero tolerance for complacency by government of West African countries in the face of the COVID-19.</title><author><name sortKey="Erhabor, O" sort="Erhabor, O" uniqKey="Erhabor O" first="O" last="Erhabor">O. Erhabor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto</wicri:regionArea><wicri:noRegion>Sokoto</wicri:noRegion></affiliation></author><author><name sortKey="Erhabor, T" sort="Erhabor, T" uniqKey="Erhabor T" first="T" last="Erhabor">T. Erhabor</name><affiliation wicri:level="1"><nlm:affiliation>Medical Laboratory Science Council of Nigeria, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Medical Laboratory Science Council of Nigeria</wicri:regionArea></affiliation></author><author><name sortKey="Adias, T C" sort="Adias, T C" uniqKey="Adias T" first="T C" last="Adias">T C Adias</name><affiliation wicri:level="1"><nlm:affiliation>Federal University Otuoke Bayelsa State, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Federal University Otuoke Bayelsa State</wicri:regionArea></affiliation></author><author><name sortKey="Okara, G C" sort="Okara, G C" uniqKey="Okara G" first="G C" last="Okara">G C Okara</name><affiliation wicri:level="1"><nlm:affiliation>West African Postgraduate College of Medical Laboratory Science, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>West African Postgraduate College of Medical Laboratory Science</wicri:regionArea></affiliation></author><author><name sortKey="Retsky, M" sort="Retsky, M" uniqKey="Retsky M" first="M" last="Retsky">M. Retsky</name><affiliation wicri:level="2"><nlm:affiliation>Harvard School of Public Health, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Harvard School of Public Health, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32417768</idno><idno type="pmid">32417768</idno><idno type="doi">10.3233/HAB-200413</idno><idno type="wicri:Area/Main/Corpus">001263</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001263</idno><idno type="wicri:Area/Main/Curation">001263</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001263</idno><idno type="wicri:Area/Main/Exploration">001263</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Zero tolerance for complacency by government of West African countries in the face of the COVID-19.</title><author><name sortKey="Erhabor, O" sort="Erhabor, O" uniqKey="Erhabor O" first="O" last="Erhabor">O. Erhabor</name><affiliation wicri:level="1"><nlm:affiliation>Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto</wicri:regionArea><wicri:noRegion>Sokoto</wicri:noRegion></affiliation></author><author><name sortKey="Erhabor, T" sort="Erhabor, T" uniqKey="Erhabor T" first="T" last="Erhabor">T. Erhabor</name><affiliation wicri:level="1"><nlm:affiliation>Medical Laboratory Science Council of Nigeria, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Medical Laboratory Science Council of Nigeria</wicri:regionArea></affiliation></author><author><name sortKey="Adias, T C" sort="Adias, T C" uniqKey="Adias T" first="T C" last="Adias">T C Adias</name><affiliation wicri:level="1"><nlm:affiliation>Federal University Otuoke Bayelsa State, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Federal University Otuoke Bayelsa State</wicri:regionArea></affiliation></author><author><name sortKey="Okara, G C" sort="Okara, G C" uniqKey="Okara G" first="G C" last="Okara">G C Okara</name><affiliation wicri:level="1"><nlm:affiliation>West African Postgraduate College of Medical Laboratory Science, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>West African Postgraduate College of Medical Laboratory Science</wicri:regionArea></affiliation></author><author><name sortKey="Retsky, M" sort="Retsky, M" uniqKey="Retsky M" first="M" last="Retsky">M. Retsky</name><affiliation wicri:level="2"><nlm:affiliation>Harvard School of Public Health, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Harvard School of Public Health, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j">Human antibodies</title><idno type="eISSN">1875-869X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32417768</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-869X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>May</Month><Day>09</Day></PubDate></JournalIssue><Title>Human antibodies</Title><ISOAbbreviation>Hum Antibodies</ISOAbbreviation></Journal><ArticleTitle>Zero tolerance for complacency by government of West African countries in the face of the COVID-19.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3233/HAB-200413</ELocationID><Abstract><AbstractText>A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Erhabor</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erhabor</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Laboratory Science Council of Nigeria, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adias</LastName><ForeName>T C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Federal University Otuoke Bayelsa State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okara</LastName><ForeName>G C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>West African Postgraduate College of Medical Laboratory Science, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Retsky</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Harvard School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Hum Antibodies</MedlineTA><NlmUniqueID>9711270</NlmUniqueID><ISSNLinking>1093-2607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">West Africa</Keyword><Keyword MajorTopicYN="N">Zero tolerance</Keyword><Keyword MajorTopicYN="N">complacency</Keyword><Keyword MajorTopicYN="N">government</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32417768</ArticleId><ArticleId IdType="pii">HAB200413</ArticleId><ArticleId IdType="doi">10.3233/HAB-200413</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Nigeria</li><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><country name="Nigeria"><noRegion><name sortKey="Erhabor, O" sort="Erhabor, O" uniqKey="Erhabor O" first="O" last="Erhabor">O. Erhabor</name></noRegion><name sortKey="Adias, T C" sort="Adias, T C" uniqKey="Adias T" first="T C" last="Adias">T C Adias</name><name sortKey="Erhabor, T" sort="Erhabor, T" uniqKey="Erhabor T" first="T" last="Erhabor">T. Erhabor</name><name sortKey="Okara, G C" sort="Okara, G C" uniqKey="Okara G" first="G C" last="Okara">G C Okara</name></country><country name="États-Unis"><region name="Massachusetts"><name sortKey="Retsky, M" sort="Retsky, M" uniqKey="Retsky M" first="M" last="Retsky">M. Retsky</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000232 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000232 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32417768
|texte= Zero tolerance for complacency by government of West African countries in the face of the COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32417768" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |